1. Home
  2. DRD vs NEO Comparison

DRD vs NEO Comparison

Compare DRD & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$24.02

Market Cap

2.1B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$16.51

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
NEO
Founded
1895
2001
Country
South Africa
United States
Employees
N/A
N/A
Industry
Precious Metals
Precision Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2002
2008

Fundamental Metrics

Financial Performance
Metric
DRD
NEO
Price
$24.02
$16.51
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
★ $21.85
AVG Volume (30 Days)
197.2K
★ 2.0M
Earning Date
10-23-2026
10-28-2026
Dividend Yield
★ 4.19%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.33
$10.71
Revenue Next Year
$18.47
$9.96
P/E Ratio
$15.32
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.47
$7.07
52 Week High
$39.37
$20.15

Technical Indicators

Market Signals
Indicator
DRD
NEO
Relative Strength Index (RSI) 42.91 44.46
Support Level $23.19 $15.57
Resistance Level $26.30 $17.19
Average True Range (ATR) 0.65 0.97
MACD 0.07 -0.06
Stochastic Oscillator 27.89 23.63

Price Performance

Historical Comparison
DRD
NEO

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment, including exploration, extraction, processing, and smelting. Its reportable operating segments are: Ergo and FWGR. Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and FWGR is a surface gold retreatment operation that treats old slime dams in the West Rand goldfields. The Ergo segment derives the vast majority of the company's revenue.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: